Search - tctmd.com

Displaying 101 - 120 of 245

Sort: Relevancy | Date

Presentation TCT 2022

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Presenter: Deepak Bhatt

September 18, 2022

Presentation TCT 2022

Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Presenter: Ajay Kirtane

September 18, 2022

Presentation TCT 2022

Case 3: Post-Partum May-Thurner Acute DVT

Presenter: Maya Serhal

September 18, 2022

Presentation TCT 2022

Case 2: COVID Patient With Clot in Transit

Presenter: Matthew Finn

September 18, 2022

Presentation TCT 2022

Case 1: Catastrophic PE With Shock

Presenter: Sanjum Sethi

September 18, 2022

Presentation TCT 2022

Drug Elution: Challenges and Opportunities

Presenter: Sahil Parikh

September 18, 2022

Presentation TCT 2022

Scaffolds Are Back: What's Old Is New

Presenter: Brian DeRubertis

September 18, 2022

Presentation TCT 2022

Atherectomy as an Adjunct to Long Term Patency

Presenter: Peter Monteleone

September 18, 2022

Presentation TCT 2022

Role of Drug-Eluting Technologies as Definitive Therapy

Presenter: Beau Hawkins

September 18, 2022

Presentation TCT 2022

Latest innovations in Thrombectomy for Venous Thromboembolism

Presenter: Lawrence Garcia

September 18, 2022

Presentation TCT 2022

Power Aspiration: Key Results from the CHEETAH Study

Presenter: J. Dawn Abbott

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Reflow Medical’s Temporary Spur DES System

Presenter: Jihad Mustapha

September 17, 2022

Presentation TCT 2022

MOTIV BRS (REVA Vascular)

Presenter: Christopher Metzger

September 17, 2022

Presentation TCT 2022

APTITUDE PLLA BRS (R3 Vascular)

Presenter: Mahmood K. Razavi

September 17, 2022

Presentation TCT 2022

Hybrid Nano-Coating DES for BTK Disease

Presenter: Terumitsu Hasebe

September 17, 2022

Presentation TCT 2022

Addressing Microvascular Obstruction and No Reflow With a Novel Nanoscale Endovascular Image-Guided Interventional Tool (Pulse NanoMED)

Presenter: Omid Akhavan

September 17, 2022

Presentation TCT 2022

First Safety and Efficacy Study of the Misago Stent in Lower Extremity Endovascular Interventions via Radial Access Approach

Presenter: Yulanka Castro

September 17, 2022

Presentation TCT 2022

Device Thrombogenicity

Presenter: Prem Midha

September 17, 2022

Presentation TCT 2022

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Presenter: Christos Rammos

September 17, 2022

Advertisement

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Case 3: Post-Partum May-Thurner Acute DVT

Case 2: COVID Patient With Clot in Transit

Case 1: Catastrophic PE With Shock

Drug Elution: Challenges and Opportunities

Scaffolds Are Back: What's Old Is New

Atherectomy as an Adjunct to Long Term Patency

Role of Drug-Eluting Technologies as Definitive Therapy

Latest innovations in Thrombectomy for Venous Thromboembolism

Power Aspiration: Key Results from the CHEETAH Study

FLASH: More Data to Support Mechanical Thrombectomy in PE

Reflow Medical’s Temporary Spur DES System

MOTIV BRS (REVA Vascular)

APTITUDE PLLA BRS (R3 Vascular)

Hybrid Nano-Coating DES for BTK Disease

Addressing Microvascular Obstruction and No Reflow With a Novel Nanoscale Endovascular Image-Guided Interventional Tool (Pulse NanoMED)

First Safety and Efficacy Study of the Misago Stent in Lower Extremity Endovascular Interventions via Radial Access Approach

Device Thrombogenicity

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content